share_log

MAI Capital Management Sells 424 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

MAI Capital Management Sells 424 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

迈资本管理公司出售直觉外科公司股份有限公司(纳斯达克代码:ISRG)424股
Defense World ·  2022/10/01 05:51

MAI Capital Management lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 10.2% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,722 shares of the medical equipment provider's stock after selling 424 shares during the period. MAI Capital Management's holdings in Intuitive Surgical were worth $747,000 at the end of the most recent quarter.

据麦资本管理公司最近提交给美国证券交易委员会的13F文件显示,该公司在第二季度减持了直觉外科公司股份有限公司(代码:ISRG-GET)10.2%。该公司在此期间出售了424股后,拥有这家医疗设备提供商的3722股股票。截至最近一个季度末,麦氏资本管理公司持有的直觉外科公司股份价值747,000美元。

A number of other hedge funds have also bought and sold shares of the company. Investment Partners LTD. boosted its position in shares of Intuitive Surgical by 4.8% during the first quarter. Investment Partners LTD. now owns 768 shares of the medical equipment provider's stock valued at $232,000 after buying an additional 35 shares during the period. Transcend Capital Advisors LLC increased its position in shares of Intuitive Surgical by 4.9% during the first quarter. Transcend Capital Advisors LLC now owns 880 shares of the medical equipment provider's stock worth $265,000 after acquiring an additional 41 shares during the period. BLB&B Advisors LLC boosted its holdings in shares of Intuitive Surgical by 6.9% in the first quarter. BLB&B Advisors LLC now owns 693 shares of the medical equipment provider's stock valued at $209,000 after purchasing an additional 45 shares during the period. Venture Visionary Partners LLC raised its position in Intuitive Surgical by 1.5% during the 1st quarter. Venture Visionary Partners LLC now owns 3,024 shares of the medical equipment provider's stock valued at $912,000 after purchasing an additional 45 shares in the last quarter. Finally, Douglass Winthrop Advisors LLC increased its stake in shares of Intuitive Surgical by 2.0% during the first quarter. Douglass Winthrop Advisors LLC now owns 2,308 shares of the medical equipment provider's stock valued at $696,000 after buying an additional 46 shares during the period. Institutional investors own 82.44% of the company's stock.

其他一些对冲基金也买卖了该公司的股票。投资伙伴有限公司第一季度将其持有的直觉外科公司股票的头寸提高了4.8%。投资伙伴有限公司在此期间又购买了35股后,现在拥有768股这家医疗设备提供商的股票,价值23.2万美元。Beyond Capital Advisors LLC在第一季度增持了4.9%的直觉外科公司股票。Transcend Capital Advisors LLC在此期间额外收购了41股,现在拥有880股这家医疗设备提供商的股票,价值265,000美元。今年第一季度,BLB&B Advisors LLC增持了6.9%的直觉外科公司股票。BLB&B Advisors LLC现在拥有这家医疗设备提供商693股股票,价值20.9万美元,在此期间又购买了45股。第一季度,Venture Visionary Partners LLC将其在直觉外科公司的持股比例提高了1.5%。Venture Visionary Partners LLC现在拥有这家医疗设备提供商3,024股股票,价值912,000美元,上个季度又购买了45股。最后,道格拉斯·温斯罗普顾问有限责任公司在第一季度增持了直觉外科公司的股份,增幅为2.0%。道格拉斯·温斯罗普顾问公司现在拥有这家医疗设备提供商2,308股股票,价值696,000美元,在此期间又购买了46股。机构投资者持有该公司82.44%的股票。

Get
到达
Intuitive Surgical
直觉外科公司
alerts:
警报:

Insider Transactions at Intuitive Surgical

直觉外科公司的内幕交易

In related news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Myriam Curet sold 9,000 shares of the business's stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold 101,162 shares of company stock valued at $22,062,916 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

在相关新闻中,董事在8月3日星期三的一次交易中出售了6,375股该公司的股票。这些股票的平均价格为238.04美元,总价值为1,517,505.00美元。交易完成后,董事现在直接拥有该公司11,224股,价值约2,671,760.96美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。在相关新闻中,执行副总裁Myriam Curet在7月27日星期三的一次交易中出售了9000股该公司的股票。这些股票的平均价格为225.00美元,总价值为2,025,000.00美元。出售完成后,执行副总裁总裁现在持有该公司217股股票,价值约48,825美元。这笔交易是在提交给美国证券交易委员会的法律文件中披露的,该文件可通过此超链接。此外,在8月3日星期三的一次交易中,董事出售了6,375股该股。这些股票的平均价格为238.04美元,总成交金额为1,517,505.00美元。交易完成后,董事现在直接拥有该公司11,224股股份,价值2,671,760.96美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士已经出售了101,162股公司股票,价值22,062,916美元。公司内部人士目前持有该公司0.90%的股份。

Intuitive Surgical Stock Performance

直觉外科公司股票表现

Shares of ISRG opened at $187.44 on Friday. The business's 50-day moving average is $216.24 and its two-hundred day moving average is $230.27. The company has a market capitalization of $66.94 billion, a P/E ratio of 47.69, a P/E/G ratio of 5.36 and a beta of 1.31. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69.
上周五,ISRG的股价开盘报187.44美元。该业务的50日移动均线切入位在216.24美元,200日移动均线切入位在230.27美元。该公司市值为669.4亿美元,市盈率为47.69,市盈率为5.36,贝塔系数为1.31。直觉外科公司的股价为184.94美元,为52周低点,52周高点为369.69美元。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). The company had revenue of $1.52 billion during the quarter, compared to analysts' expectations of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter in the previous year, the company earned $1.42 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 3.76 EPS for the current year.

直觉外科公司(纳斯达克代码:ISRG-GET Rating)最近一次发布收益报告是在7月21日星期四。这家医疗设备供应商公布本季度每股收益为0.85美元,低于分析师普遍预期的1.04美元(0.19美元)。该公司本季度营收为15.2亿美元,高于分析师预期的15.6亿美元。直觉外科公司的股本回报率为12.04%,净利润率为24.05%。去年同期,该公司每股收益为1.42美元。分析师预测,直觉外科公司公司本年度每股收益将达到3.76股。

Analysts Set New Price Targets

分析师设定新的价格目标

Several equities analysts recently issued reports on ISRG shares. Evercore ISI cut their price objective on shares of Intuitive Surgical from $210.00 to $175.00 in a report on Friday, July 22nd. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Morgan Stanley decreased their target price on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating for the company in a research report on Friday, July 15th. Raymond James reduced their price target on Intuitive Surgical from $294.00 to $255.00 in a research report on Friday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Intuitive Surgical from $225.00 to $205.00 in a research report on Friday, July 22nd. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $268.00.

几位股票分析师最近发布了关于ISRG股票的报告。在7月22日星期五的一份报告中,Evercore ISI将直觉外科公司的股票目标价从210.00美元下调至175.00美元。9月9日,Stifel Nicolaus在一份报告中将直觉外科公司股票的目标价从250.00美元上调至260.00美元,并给予该公司“买入”评级。7月15日,摩根士丹利在一份研究报告中将直觉外科公司股票的目标价从300.00美元下调至225.00美元,并为该公司设定了“同等权重”的评级。雷蒙德·詹姆斯在7月22日星期五的一份研究报告中将直觉外科公司的目标价从294.00美元下调至255.00美元。最后,德意志银行Aktiengesellschaft在7月22日(周五)的一份研究报告中将直觉外科公司的目标价从225.00美元下调至205.00美元。6名研究分析师对该股的评级为持有,12名分析师对该公司股票的评级为买入。根据MarketBeat的数据,该股目前的平均评级为“中等买入”,平均目标价为268.00美元。

About Intuitive Surgical

关于直觉外科公司

(Get Rating)

(获取评级)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直觉外科公司公司开发、制造和营销产品,使医生和医疗保健提供者能够在美国和国际上提高微创护理的质量和获得微创护理的机会。该公司提供达芬奇外科系统,以实现使用微创方法进行复杂手术;以及离子腔内系统,将其商业产品从外科扩展到能够进行微创肺活组织检查的诊断程序。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • 免费获取斯托克新闻网关于直觉外科公司的研究报告
  • 电动汽车电池制造商Freyr将在全球大举扩张
  • MarketBeat:回顾一周9/26-9/30
  • 这是买入美光科技的难忘时刻
  • 利润下降对CarMax价值主张的挑战
  • Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直觉外科公司日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对直觉外科公司及相关公司的最新新闻和分析师评级的每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发